MedTrace Logo

COr Loco-regional Advanced Lung Cancer Treated With Chemo-radiotherapy (COLA)

NCT05258448 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2023-12-06

No results posted yet for this study

Summary

Patients with loco-regional NSCLC planned for curative treatment with chemoradiotherapy will be invited to participate in a prospective study; besides routine treatment, the patients will be followed with an ECG and cardiac MR for at least two years after radiotherapy treatment.

Conditions

  • Cardiac Toxicity
  • Lung Cancer Stage III
  • Lung Cancer Stage II
  • Radiation Toxicity
  • Cardiac Disease

Interventions

OTHER

Chemoradiotherapy

Cardiac Magnetic Resonance scan and ECG

Sponsors & Collaborators

  • Odense University Hospital

    lead OTHER

Principal Investigators

  • Tine Schytte, Professor · Odense University Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-08-31
Primary Completion
2024-08-31
Completion
2026-10-31

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05258448 on ClinicalTrials.gov